Wegovy Alternatives: Same Semaglutide, 87% Less

If you have been prescribed Wegovy for weight loss, you already know the challenge. Brand-name Wegovy (semaglutide by Novo Nordisk) lists at approximately $1,349 per month without insurance coverage. For the millions of Americans who need this medication, that price puts it out of reach entirely.

But here is the thing most people do not realize: Wegovy is just semaglutide at a specific dosage. The same active ingredient is available through licensed compounding pharmacies at a fraction of the cost — $179 per month through Novolene, including provider oversight and free shipping.

Why People Seek Wegovy Alternatives

Wegovy was approved by the FDA in 2021 for chronic weight management and quickly became one of the most prescribed weight loss medications in the United States. But for many patients, getting Wegovy — and keeping access to it — has been a struggle. Here are the three primary reasons people look for alternatives.

Cost: The biggest barrier

At $1,349 per month, brand-name Wegovy costs over $16,000 per year. Even with commercial insurance, many patients face copays of $200 to $500 per month after deductible. Medicare does not cover weight loss medications at all. For uninsured patients or those whose plans exclude GLP-1 drugs for weight management, the full retail price is the only option.

Novolene compounded semaglutide costs $179 per month — that is $149 for the medication, $30 for the licensed provider consultation, and $0 for shipping. Over a year, that is a savings of more than $14,000 compared to brand-name Wegovy.

Insurance denials and prior authorization

Even patients with insurance that technically covers Wegovy often hit roadblocks. Insurers frequently require prior authorization, step therapy (trying and failing cheaper medications first), and proof of a BMI over 30 or over 27 with a qualifying comorbidity. The process can take weeks, and denials are common. Novolene bypasses this entirely — no insurance is needed, no prior authorization, no step therapy requirements.

Ongoing supply shortages

Wegovy has experienced repeated supply shortages since its launch. Novo Nordisk has struggled to manufacture enough pre-filled pens to meet surging demand. Patients have reported waiting weeks or months to fill prescriptions, or being told their pharmacy has no stock available. Compounded semaglutide from FDA-regulated pharmacies offers a more reliable supply chain, so you are not left without medication.

What Is Wegovy, Exactly?

Understanding what Wegovy actually is makes it easier to see why alternatives work just as well. Wegovy is semaglutide — a GLP-1 (glucagon-like peptide-1) receptor agonist — manufactured by Novo Nordisk and packaged in pre-filled injection pens at weight loss doses (0.25 mg, 0.5 mg, 1 mg, 1.7 mg, and 2.4 mg).

Semaglutide works by mimicking the GLP-1 hormone your body naturally produces after eating. This hormone signals fullness to your brain, slows gastric emptying, and helps regulate blood sugar. The result is a significant reduction in appetite and caloric intake.

The STEP clinical trials showed that semaglutide at the 2.4 mg dose, combined with lifestyle changes, produced an average body weight reduction of approximately 15% over 68 weeks. That is why it has been called a breakthrough in obesity treatment.

But here is the key point: the active ingredient doing all the work is semaglutide. Whether it comes in a Novo Nordisk pen labeled Wegovy or from a licensed compounding pharmacy, the molecule is the same. The efficacy comes from the semaglutide itself, not the brand name on the packaging.

Compounded Semaglutide: The Same Active Ingredient at a Fraction of the Cost

Compounded semaglutide is the identical active ingredient as Wegovy, produced in FDA-regulated compounding pharmacies that must meet strict quality and safety standards. It works the same way in your body — activating GLP-1 receptors to reduce appetite, slow digestion, and support sustained weight loss.

The practical difference is the delivery method. Brand-name Wegovy comes in a proprietary pre-filled injection pen from Novo Nordisk. Compounded semaglutide is produced by licensed compounding pharmacies and typically comes in a sterile vial with insulin syringes for subcutaneous injection. The injection is the same — a small needle placed just under the skin, typically in the abdomen, once per week.

How Novolene pricing works

Novolene uses transparent, partitioned pricing so you always know exactly what you are paying for:

• $149/month — the compounded semaglutide medication
• $30/month — licensed provider consultation and ongoing oversight
• $0 — shipping (always free, always discreet)

Your price stays the same from the starting dose all the way through the highest maintenance dose. There are no hidden fees, no price increases as you titrate up, and no insurance paperwork.

Is compounded semaglutide safe?

Compounded medications are produced in FDA-regulated facilities that must comply with United States Pharmacopeia (USP) standards and state pharmacy board regulations. These are the same compounding pharmacies that produce medications for hospitals and clinics across the country. At Novolene, every prescription is reviewed and written by a licensed medical provider who evaluates your full health profile before prescribing.

Tirzepatide: A Dual-Action Wegovy Alternative

If you are exploring Wegovy alternatives, tirzepatide is another option worth serious consideration. While semaglutide targets only the GLP-1 receptor, tirzepatide activates both GIP and GLP-1 receptors — a dual-action mechanism that clinical trials have shown can produce even greater weight loss results.

The SURMOUNT clinical trials demonstrated that tirzepatide at the highest dose produced up to 22.5% body weight reduction over 72 weeks, compared to semaglutide's approximately 15% at the Wegovy dose. For patients who want maximum results, tirzepatide may be the more effective option.

Brand-name tirzepatide (Mounjaro for diabetes, Zepbound for weight loss by Eli Lilly) costs $1,000 or more per month. Novolene offers compounded tirzepatide from $299 per month — less than one-third the brand-name price, with the same active ingredient.

Wegovy Alternatives Comparison

As the table shows, Novolene compounded semaglutide delivers the same active ingredient as Wegovy with the same expected results. Novolene compounded tirzepatide offers a different — and potentially more effective — mechanism of action at still dramatically lower prices than any brand-name option.

How Novolene Works

Getting started with a Wegovy alternative through Novolene is straightforward and takes just a few days from evaluation to medication at your door.

1. Free online evaluation — Answer health questions about your weight goals, medical history, current medications, and any prior experience with GLP-1 drugs. Takes about 5 minutes. No commitment required.
2. Provider review — A licensed medical provider reviews your complete health profile to determine whether semaglutide or tirzepatide is appropriate for you, and at what starting dose.
3. Prescription shipped to your door — If approved, your medication is prepared by an FDA-regulated compounding pharmacy and shipped in discreet, temperature-controlled packaging with everything you need to get started.
4. Ongoing provider support — Your licensed provider remains available for questions, dose adjustments, and ongoing guidance throughout your treatment. There are no extra fees for follow-up consultations.

Wegovy Alternatives FAQ